BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

AngioDynamics (ANGO) Still Growing Strong, Plans More Jobs


10/22/2012 8:46:46 AM

AngioDynamics Inc. President and CEO Joe DeVivo doesn’t flinch when asked about his firm’s future in the Glens Falls area. “It’s going to be a hell of a company,” he said during an interview Wednesday at AngioDynamics’ Glens Falls facility off Dix Avenue. “We’ve gone through the pain this year to build a foundation. Today, I think we have a strong operating team that’s ready for growth, and now it’s just a matter of us being opportunistic, letting our (research and development) pay off, letting our top line grow, and then, as we grow, so does our footprint, and so do the opportunities.” AngioDynamics was founded in 1988 by Eamonn Hobbs, who today is CEO of Delcath Systems Inc., another medical device maker with operations in Catheter Valley. AngioDynamics’ product portfolio has grown over the years to include a range of high-tech catheters and devices for treating periphery vascular disease and cancer. Originally known as the North American Medical Instruments Corp., the Navilyst facility is no stranger to buyouts. The AngioDynamics purchase is the fourth such deal struck for the plant since 1998.

Read at News Release

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES